The pharmaceutical research department have platforms for research and development of innovative drug and pharmaceutical intermediates. It has drug synthesis and drug process programs, which is mainly engaged in the development and research of anti-tumor and anti-infection drugs and the synthesis and improvement of pharmaceutical intermediates. At present, our team has made progress in the research and development of pharmaceutical intermediates 7-ACCA and small molecule IDO inhibitors. 7-ACCA which is a key intermediate of the antibiotic Cefaclor has completed the process development. The innovative drug IDO inhibitor has applied for PCT, and compound patents have entered the United States, the European Union, Japan and South Korea. At the same time, the laboratory is also conducting research on other anti-tumor innovative drugs, plant growth regulators and key intermediates of tranexamic acid. Up to now, the team has applied for more than twenty patents of Chinese and PCT, and obtained patent authorization from China, the United States, Japan, South Korea, Taiwan and other countries and regions.
The pharmaceutical laboratory will cooperate with the outside with an open attitude, expecting to carry out cooperation and services in new drug project research, technology development of pharmaceutical intermediates, drug activity screening, pharmacokinetic research and other related fields.
Contact Us: 85869266、85869151、18540366266、18540366378